« FDA's 2007 Report On Outstanding Post-approval Studies: No Progress Made By Big Pharma | Main | FDA Says It Doesn't Know How Long Defective Digitek / Digoxin Pills Were Sold »

Digitek Digoxin Recall: Tablets May Be Double The Normal Dose

So-called "Digitalis Toxicity" Is Possible, Especially In Patients With Renal Failure

(Posted by Tom Lamb at DrugInjuryWatch.com)

In an April 28, 2008 MedWatch Safety Alert about Digitek (digoxin tablets), the FDA informed doctors and patients that this prescription medication is the subject of a nationwide Class I recall because of the possibility that some tablets were manufactured such that they contain twice the approved level of active ingredient.

In more detail, according to this Digitek MedWatch Safety Alert:

  • The products are distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label.
  • The existence of double strength tablets poses a risk of digitalis toxicity in patents with renal failure.
  • Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia.

This April 28 MedWatch Safety Alert came several days after a press release about this Digitek manufacturing problem was issued by Actavis Totowa LLC (formerly known as Amide Pharmaceutical Inc).  Therein, the manufacturer said it is recalling all strengths of Digitek because it may have accidentally released pills that are double the normal thickness, carrying twice the normal dose.

Digoxin is used in the treatment of arrhythmias and heart failure.

Patients taking Digitek tablets should contact their doctor if they have any concerns or questions.

P.S.  According to a brief newspaper article dated April 25, 2008, "Digitek heart drug recall":

[Actavis Totowa LLC spokesman] John LaRocca said 11 people have reported getting sick after taking the drug, but the Morristown, N.J., company is not aware of any deaths.

We will keep you informed about the number of patients injured by Digitek (digoxin) tablets that were defective, i.e., manufactured with a double-dose, as well as anything that we learn about the dates when these recalled Digitek tablets were being dispensed at pharmacies across the country. 

My law firm has been contacted already by several people who have had family members hospitalized with serious side effects apparently caused by the defective Digitek tablets.  We are in the process of investigating possible Digitek cases where the patient was hospitalized or that involve a death that may be related to the person's use of Digitek tablets.  (5/1/08)

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341c89dd53ef00e5520679448833

Listed below are links to weblogs that reference Digitek Digoxin Recall: Tablets May Be Double The Normal Dose:

Comments

My Photo

Get New Posts By Email, Free

RSS Feed

  • FeedBurner

Search Engine

  • Google

    WWW
    www.drug-injury.com

Advisory

  • You should not stop taking any prescription drug before talking to your doctor.

Case Review

Sponsored By

Web 2.0 Tools

  • Add to Technorati Favorites
AddThis Social Bookmark Button

Twitter Updates

    follow me on Twitter

    Tips & Tidbits


    Resources

    • ConsumerMedSafety.org
      A portal of information provided by the Institute for Safe Medication Practices.
    • Drug Interaction Checker
      Program alerts patients to some drug-drug interaction possibilities when taking two or more prescription drugs.
    • FDA MedWatch
      MedWatch is the U.S. FDA site for safety information on prescription drugs and other medical products.
    • Health Canada MedEffect
      Health Canada's MedEffect site provides drug product safety announcements and other information for patients.
    • Medication Errors Reporting Program (MERP)
      Submit a confidential report to national voluntary program.
    • NIH MedlinePlus
      MedlinePlus will direct you to information that will help answer health questions.
    • Patient Medical Records Copying Cost Statutes
      State statutes that control what amount can be charged when patient requests their own medical records in U.S.
    • PDRhealth.com
      Based on most trusted database of prescription drug information, Physicians’ Desk Reference.
    • PharmedOut
      Intended to help prescribers identify and counter inappropriate pharmaceutical promotion practices.

    Sites to See

    Other News

    Common Feed

    • FeedBurner

    Affiliations

    • US Business Directory & Local Blogs
    • lawyer blogs
    • Medicine Blogs - BlogCatalog Blog Directory
    • Law Blogs - Blog Top Sites
    • Blog
    • Alltop, all the top stories
    • BlogBurst.com

    Blog Archives

    Custom Feeds

    • Add Drug Injury Watch to Newsburst from CNET News.com

    • Add to My AOL

    • Subscribe in NewsGator Online

    • Add to Google

    • Subscribe in Bloglines

    HitTail.com

    Disclaimer


    • DRUG INJURY WATCH is for general information purposes only, and should not be regarded as medical advice or legal advice.... (For more, please see the About page.)

    See You Again